WSA
ELOS

Wall Street Associates’s Syneron Medical Ltd ELOS Stock Holding History

Wall Street Associates’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-143,700
Closed -$1.77M – 356
2013
Q4 		$1.77M Buy
143,700
+6,200
+5% +$64.4K 0.15% 182
2013
Q3 		$1.19M Buy
137,500
+600
+0.4% +$5.18K 0.11% 197
2013
Q2 		$1.19M Buy
+136,900
New +$1.22M 0.12% 182

Other funds holding ELOS

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return

Wall Street Associates's ELOS Position: Q1 2014 in Review

Wall Street Associates sold out of Syneron Medical Ltd (ELOS) in Q1 2014, closing a stake of 143,700 shares — an estimated $1.77M sold.

Wall Street Associates first reported a position in ELOS in Q2 2013 and held it in 3 quarters. The position peaked at $1.77M in Q4 2013. 71 funds tracked by Wall St. Rank hold ELOS as of Q1 2014.

  • Wall Street Associates reported no remaining Syneron Medical Ltd position as of Q1 2014 after selling out during the quarter.
  • Wall Street Associates sold 143,700 Syneron Medical Ltd shares in Q1 2014, an estimated $1.77M.
  • Wall Street Associates first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 3 quarters.
  • Wall Street Associates's Syneron Medical Ltd position peaked at $1.77M in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2014.

Based on Wall Street Associates's 13F filing for Q1 2014, filed 13 May 2014.